The Latest Breaking News from Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

Youngsters to be offered shots from Wednesday

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

The Department of Medical Science is seeking volunteers who received the smallpox vaccine when it was still being widely administered prior to 1980 to test whether they have been left with any residual immunity against monkeypox having successfully cultivated test strains of the new virus in their laboratories.

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years

The first 3,500 doses will be available to Victorians most at risk of contracting the virus, which has spread to more than 70 countries and infected about 26,000 people around the world.

The UK Health Security Agency has repeatedly detected the poliovirus in London’s sewage works and is now calling on parents to make sure their children are fully vaccinated

When UK authorities granted permission in October 2020 for the first controlled infection study to be carried out to test the anti-Covid-19 vaccine Oxford University had just developed, reactions ranged from disbelief to disapproval.

Monkeypox cases across the UK are on the rise. Amidst World Health Organisation concerns, Public Health Scotland's vaccine program is getting under way despite limited global supply.